Heart Failure & SGLT2is: The New Pillar in Care

Heart Failure & SGLT2is: The New Pillar in Care

What You Will Learn

Current heart failure patient management challenges

How to distinguish pathophysiologic characteristics of HF

Guideline-directed medical therapy for HF patients

How to customize the treatment plans for HFrEF and HFpEF patients

Interprofessional team strategies to improve care coordination and communication

Welcome to Heart Failure & SGLT2is: The New Pillar in Care

Patient Case Quizzes

Apply your knowledge to patient case scenarios.

Heart Failure Fact or Fiction: Management of HFpEF

Heart Failure Fact or Fiction: Preventing HF

Heart Failure Fact or Fiction: Optimizing GDMT - Dose vs. Mechanism of Action

Heart Failure Fact or Fiction: BP, How Low Is Too Low?

Heart Failure Fact or Fiction: Creatine’s Cautionary Tale

Heart Failure Fact or Fiction: Early Recognition of HF Risk

Heart Failure Fact or Fiction: Management of HFrEF

Heart Failure Fact or Fiction: Hyperkalemia and SGLT2i

Online Course

Coming in 2023

Get Started

Topic 1: Challenges in HF Management

Topic 2: Pathophysiology

Topic 3: SGLT2is for HF Prevention

Topic 4: Guideline-Directed Medical Therapy for HF

Topic 5: Customized Treatment Plan for HFrEF

Topic 6: Customized Treatment Plan for HFpEF

Topic 7: Team-Based Care for HF

Topic 8: Lifestyle

Final Quiz - Test your knowledge.

Micro Learning

ACC’s Quick Tips for Fast Thinking provide easy to access information to support you at the moment you need it.

Coming Soon

Podcasts

Listen to experts discuss the latest clinical education.

Coming Soon

Resources

A collection of resources about SGLT2is and treating HF.

Learn More

We are grateful to these distinguished faculty who contributed to this collection:

Chairs

Alison Bailey, MD, FACC

James L. Januzzi, Jr., MD, FACC

Faculty

Alexander Hajduczok, MD

Quentin R Youmans, MD

Vanessa Blumer, MD

Educational Grant Support Provided By: Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly)

Page Launched: October 2022